Health In Tech, Inc. has announced a significant financial move, entering into a Standby Equity Purchase Agreement (SEPA) that will allow the company to issue up to $10 million in promissory notes. This financing is expected to enhance the company’s liquidity and support its growth initiatives within the insurance sector.
The company completed the second closing of this financing on November 2, 2026, issuing a second promissory note for $3 million to YA II PN, Ltd., the investor involved in the SEPA. The total amount raised through these notes now stands at $10 million, with a portion of the funds already disbursed to Health In Tech.
Health In Tech operates under the SIC classification of 6411, which encompasses insurance agents, brokers, and service providers. The company is listed on the Nasdaq under the ticker symbol HIT and is categorized as an emerging growth company.
According to the recent SEC filing, the promissory notes carry an interest rate of 8.75% per annum, which could increase to 18% in the event of default. The notes will mature on February 18, 2028, and include provisions for installment payments that can be satisfied either in cash or through the sale of Class A common stock.
In addition to the financing, Health In Tech is seeking shareholder approval for the issuance of shares that exceed the Exchange Cap of approximately 13.1 million shares. This request will be presented at the company’s annual meeting scheduled for November 10, 2026.
The financing strategy reflects Health In Tech's ongoing efforts to strengthen its financial position and enhance its competitive edge in the insurance market. As the company continues to innovate and expand its service offerings, the successful execution of this financing will be crucial in supporting its growth trajectory.
Health In Tech's recent actions may also influence other players in the insurance industry as companies look for ways to secure funding and adapt to changing market conditions. The move highlights the importance of strategic financing in maintaining operational flexibility and pursuing growth opportunities in a competitive landscape.
Details were not available in the SEC filing regarding any further steps following the shareholder vote.
Read Next
Q/C Technologies Enters Omnibus Amendment Agreement
ONE Nuclear Energy settles consulting fees with stock issuance
HCW Biologics delays stockholder vote amid quorum issues
bioAffinity Technologies amends share structure in 8-K filing
VisionWave amends sponsorship deal with Hen Basketball Haifa Club
Apimeds Pharmaceuticals Amends Agreement with FreeT Inc.










